The impact of the COVID-19 pandemic on rheumatic heart disease

The COVID-19 pandemic has significantly impacted cardiovascular disease, particularly rheumatic heart disease (RHD). Importantly, RHD has been shown to be a significant risk factor for the prognosis of COVID-19, with severe valvular heart disease leading to poorer clinical outcomes of COVID-19 infection. Regardless, interest and prioritization of RHD in the world agenda remain low, even after the pandemic. Medical appointments, compliance with medical treatment, and prophylaxis should be encouraged. Prioritization of RHD research and efforts to improve diagnosis, treatment, prevention, and care are warranted.